Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Lystrup Tandklinik I/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   28.8% 32.4% 20.2% 7.3% 15.4% 9.2% 16.3% 16.3%   Credit score (0-100)   3 1 5 33 12 27 11 11   Credit rating   B C B BBB BB BB BB BB   Credit limit (kDKK)   -0.0 -0.0 -0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,657 1,660 1,474 5,515 6,816 7,995 0.0 0.0   EBITDA   -1,677 -1,789 -1,900 1,224 1,868 2,035 0.0 0.0   EBIT   -1,677 -1,789 -1,900 1,214 1,837 1,869 0.0 0.0   Pre-tax profit (PTP)   -1,675.1 -1,789.6 -1,905.1 1,210.3 1,847.9 1,865.2 0.0 0.0   Net earnings   -1,675.1 -1,789.6 -1,905.1 1,210.3 1,847.9 1,865.2 0.0 0.0   Pre-tax profit without non-rec. items   -1,675 -1,790 -1,905 1,210 1,848 1,865 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 87.3 135 754 0.0 0.0   Shareholders equity total   -418 -707 -60.9 689 -108 345 345 345   Interest-bearing liabilities   66.1 236 0.0 0.0 0.0 84.2 0.0 0.0   Balance sheet total (assets)   170 428 494 1,276 722 1,013 345 345   Net Debt   58.8 189 -149 -825 -285 81.7 -345 -345     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,657 1,660 1,474 5,515 6,816 7,995 0.0 0.0   Gross profit growth   -17.5% 0.2% -11.2% 274.2% 23.6% 17.3% -100.0% 0.0%   Employees   0 8 8 10 11 12 0 0   Employee growth %   0.0% 0.0% 0.0% 25.0% 10.0% 9.1% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   170 428 494 1,276 722 1,013 345 345   Balance sheet change%   -17.3% 151.0% 15.5% 158.3% -43.4% 40.2% -65.9% 0.0%   Added value   -1,676.6 -1,789.4 -1,900.3 1,223.9 1,846.4 2,034.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 393 -785 470 17 453 -754 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -3.0 -4.0 -5.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -101.2% -107.8% -128.9% 22.0% 26.9% 23.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -274.2% -207.4% -224.7% 133.2% 175.5% 202.9% 0.0% 0.0%   ROI %   -1,091.4% -937.5% -1,610.6% 354.0% 536.8% 870.4% 0.0% 0.0%   ROE %   -889.3% -598.2% -413.2% 204.6% 261.9% 349.3% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   -71.7% -62.5% -11.1% 54.0% -13.2% 34.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -3.5% -10.6% 7.8% -67.4% -15.3% 4.0% 0.0% 0.0%   Gearing %   -15.8% -33.4% 0.0% 0.0% 0.0% 24.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.1% 1.3% 5.0% 0.0% 0.0% 11.4% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.3 0.5 0.9 2.0 0.7 0.4 0.0 0.0   Current Ratio   0.3 0.5 0.9 2.0 0.7 0.4 0.0 0.0   Cash and cash equivalent   7.3 47.0 148.8 825.0 285.3 2.6 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -356.2 -488.4 -78.0 584.4 -259.9 -425.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 -224 -238 122 168 170 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 -224 -238 122 170 170 0 0   EBIT / employee   0 -224 -238 121 167 156 0 0   Net earnings / employee   0 -224 -238 121 168 155 0 0